Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination : Benefits: Appetite Suppression Weight Loss Enhanced Satiety Improved Glycemic Control Perfect Combo: When paired with GLP Development of Cagrilintide, a Long Acting Amylin Analogue Journal of Medicinal Chemistry Cagrilintide and semaglutide together drive record weight loss in global trial Three new #obesity drugshigh dose semaglutide, semaglutide plus cagrilintide, and oral orforglipronmay soon be approved in the US. JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin examine how Cagrilintide: What It Is and How It's Being Studied for Weight Loss